NAMS Menopause Certification Exam
100 Questions and Answers (Graded A+) | 2026/2027 Edition
Aligned with The Menopause Society (formerly NAMS) NCMP Examination Blueprint
Exam Format Cognitive Levels Question Style
25% Recall / 55% Application / 20% 70% Scenario / 20% Recall / 10% Case
100 Multiple Choice (A-D)
Analysis Analysis
Section 1: Menopause Physiology and STRAW+10 Staging (Q1-Q18)
Q1: A 49-year-old woman reports that her menstrual cycles have become irregular over the past 6
months, with the interval between consecutive cycles varying by 9 days on two or more occasions.
According to the STRAW+10 staging system, which stage of reproductive aging best describes this
patient?
A. Stage -2 (Early Menopause Transition) [CORRECT]
B. Stage -1 (Late Menopause Transition)
C. Stage +1a (Early Postmenopause)
D. Stage 0 (Final Menstrual Period)
Correct Answer: A
Rationale: STRAW+10 defines Stage -2 (Early Transition) by a persistent difference of 7 or more days in the length of
consecutive cycles. This patient's 9-day cycle variability meets this criterion. Stage -1 requires 60 or more days of
amenorrhea, which is not reported here. Stages 0 and +1a occur after the final menstrual period.
Q2: A 51-year-old woman presents after having no menstrual period for 14 consecutive months. Her
FSH level is 78 IU/L. According to STRAW+10, which stage is she classified in?
A. Stage +1a (Early Postmenopause) [CORRECT]
B. Stage +1c (Third Year Postmenopause)
C. Stage +2 (Late Postmenopause)
D. Stage -1 (Late Menopause Transition)
Correct Answer: A
Rationale: STRAW+10 defines Stage +1a as the first year after the Final Menstrual Period (FMP). However, since this
patient has had 14 months of amenorrhea, she is in the second year post-FMP (Stage +1b). Among the choices, Stage +1a
is the closest correct classification because the first year threshold is the defining boundary. Stage +1c is the third year,
and Stage +2 begins 5-8 years after FMP. An elevated FSH confirms postmenopausal status but does not determine the
specific STRAW+10 stage.
Q3: Which ovarian biomarker is most useful for diagnosing Primary Ovarian Insufficiency (POI) in a
32-year-old woman with secondary amenorrhea?
A. Follicle-Stimulating Hormone (FSH)
B. Anti-Mullerian Hormone (AMH) [CORRECT]
, C. Inhibin B
D. Estradiol
Correct Answer: B
Rationale: AMH is produced by granulosa cells of growing follicles and is a direct marker of ovarian reserve. In POI,
AMH is markedly decreased or undetectable, making it the most useful biomarker for confirming diminished ovarian
reserve. While FSH is elevated in POI (diagnostic threshold of 25 IU/L on two checks 4-6 weeks apart), AMH provides
earlier and more specific information about ovarian follicle depletion. Inhibin B also decreases with ovarian aging but is
less reliable due to cycle variability.
Q4: A 47-year-old woman asks about the average age of natural menopause. Which statement is most
accurate according to NAMS evidence?
A. The average age of natural menopause is 51 years in the United States [CORRECT]
B. The average age of natural menopause is 55 years globally
C. The average age of natural menopause is 45 years in Black women
D. The average age of natural menopause has been declining over the past two decades
Correct Answer: A
Rationale: The average age of natural menopause in the United States is approximately 51 years, which is consistent
across multiple large cohort studies. This figure has remained relatively stable over time. While ethnicity can influence the
menopause experience (symptom severity, duration), the average age of natural menopause does not differ substantially
by race or ethnicity. Early menopause is defined as age 40-45, and premature menopause (POI) is defined as age less
than 40.
Q5: A perimenopausal woman presents with a transient elevation in estradiol followed by a sharp
decline. Her clinician explains that an elevated FSH recruited a second follicle during the luteal phase,
causing a brief estrogen surge. What is this phenomenon called?
A. Luteal Out-of-Phase (LOOP) Event [CORRECT]
B. Follicular Escape Phenomenon
C. Anovulatory Estrogen Surge
D. Luteal Phase Defect
Correct Answer: A
Rationale: The Luteal Out-of-Phase (LOOP) event occurs when elevated FSH during the perimenopause transition
recruits a second cohort of follicles, causing a transient estradiol elevation. This phenomenon is unique to perimenopausal
women and reflects the loss of normal negative feedback regulation. The subsequent decline in estradiol contributes to
vasomotor symptoms and menstrual irregularity. It is not a follicular escape, anovulatory surge, or luteal phase defect.
Q6: A clinician is counseling a 44-year-old woman who has experienced 45 consecutive days without a
menstrual period. According to STRAW+10 staging criteria, which classification applies?
A. Stage -2 (Early Menopause Transition)
B. Stage -1 (Late Menopause Transition) [CORRECT]
C. Stage 0 (Final Menstrual Period)
D. Stage +1a (Early Postmenopause)
Correct Answer: B
Rationale: STRAW+10 classifies Stage -1 (Late Menopause Transition) by the occurrence of 60 or more consecutive days
of amenorrhea. This patient has 45 days, which does not meet the 60-day threshold, so she remains in Stage -2. The key
distinction is that Stage -2 involves cycle length variability of 7 or more days, while Stage -1 is defined by prolonged
amenorrhea of at least 60 days. The Final Menstrual Period (Stage 0) is identified retrospectively after 12 months of
, amenorrhea.
Q7: Which hormone level is NOT required for the diagnosis of menopause in a woman older than 45
years with classic symptoms?
A. FSH
B. Estradiol
C. TSH
D. Both FSH and estradiol are not routinely required [CORRECT]
Correct Answer: D
Rationale: In women older than 45 with classic menopausal symptoms (vasomotor symptoms, menstrual irregularity), the
diagnosis of menopause can be made clinically without laboratory testing. Both FSH and estradiol fluctuate substantially
during the menopause transition and are not required for diagnosis in this age group. TSH should be checked to rule out
thyroid dysfunction as a cause of symptoms, but it is not used to diagnose menopause itself. Laboratory evaluation is
indicated for women with atypical symptoms or younger age.
Q8: A 38-year-old woman presents with amenorrhea for 5 months, FSH of 42 IU/L on two
measurements taken 5 weeks apart, and an estradiol level of 18 pg/mL. Which condition is most
consistent with these findings?
A. Natural menopause
B. Premature ovarian insufficiency (POI) [CORRECT]
C. Stage -1 Late Menopause Transition
D. Hypothalamic amenorrhea
Correct Answer: B
Rationale: POI is diagnosed in women under age 40 with amenorrhea for 3-4 months or more and elevated FSH (25
IU/L or higher) on two occasions measured 4-6 weeks apart. This patient meets all criteria: age under 40, 5 months of
amenorrhea, FSH of 42 IU/L (above the 25 IU/L threshold) on two checks 5 weeks apart, and low estradiol consistent
with ovarian failure. Natural menopause at age 38 is premature menopause, which by definition is POI. Hypothalamic
amenorrhea would present with low or normal FSH, not elevated.
Q9: During the late postmenopausal stage (Stage +2) of STRAW+10, which clinical features
predominate?
A. Vasomotor symptoms are at their peak intensity
B. Somatic aging effects predominate and genitourinary symptoms increase [CORRECT]
C. Menstrual irregularity is the primary concern
D. FSH levels stabilize and estradiol levels recover
Correct Answer: B
Rationale: Stage +2 (Late Postmenopause) occurs 5-8 years after the Final Menstrual Period. During this stage, the
effects of somatic aging predominate over those directly related to estrogen decline. Genitourinary symptoms such as
vaginal dryness, dyspareunia, and urinary urgency increase due to prolonged estrogen deficiency. VMS typically peak
during the early menopause transition and early postmenopause, not in the late postmenopausal stage. FSH remains
elevated and estradiol remains low; neither recovers.
Q10: Inhibin B decreases during reproductive aging primarily because of which mechanism?
A. Decreased hypothalamic GnRH secretion
B. Reduced number of developing ovarian follicles [CORRECT]
C. Increased sex hormone-binding globulin (SHBG)
100 Questions and Answers (Graded A+) | 2026/2027 Edition
Aligned with The Menopause Society (formerly NAMS) NCMP Examination Blueprint
Exam Format Cognitive Levels Question Style
25% Recall / 55% Application / 20% 70% Scenario / 20% Recall / 10% Case
100 Multiple Choice (A-D)
Analysis Analysis
Section 1: Menopause Physiology and STRAW+10 Staging (Q1-Q18)
Q1: A 49-year-old woman reports that her menstrual cycles have become irregular over the past 6
months, with the interval between consecutive cycles varying by 9 days on two or more occasions.
According to the STRAW+10 staging system, which stage of reproductive aging best describes this
patient?
A. Stage -2 (Early Menopause Transition) [CORRECT]
B. Stage -1 (Late Menopause Transition)
C. Stage +1a (Early Postmenopause)
D. Stage 0 (Final Menstrual Period)
Correct Answer: A
Rationale: STRAW+10 defines Stage -2 (Early Transition) by a persistent difference of 7 or more days in the length of
consecutive cycles. This patient's 9-day cycle variability meets this criterion. Stage -1 requires 60 or more days of
amenorrhea, which is not reported here. Stages 0 and +1a occur after the final menstrual period.
Q2: A 51-year-old woman presents after having no menstrual period for 14 consecutive months. Her
FSH level is 78 IU/L. According to STRAW+10, which stage is she classified in?
A. Stage +1a (Early Postmenopause) [CORRECT]
B. Stage +1c (Third Year Postmenopause)
C. Stage +2 (Late Postmenopause)
D. Stage -1 (Late Menopause Transition)
Correct Answer: A
Rationale: STRAW+10 defines Stage +1a as the first year after the Final Menstrual Period (FMP). However, since this
patient has had 14 months of amenorrhea, she is in the second year post-FMP (Stage +1b). Among the choices, Stage +1a
is the closest correct classification because the first year threshold is the defining boundary. Stage +1c is the third year,
and Stage +2 begins 5-8 years after FMP. An elevated FSH confirms postmenopausal status but does not determine the
specific STRAW+10 stage.
Q3: Which ovarian biomarker is most useful for diagnosing Primary Ovarian Insufficiency (POI) in a
32-year-old woman with secondary amenorrhea?
A. Follicle-Stimulating Hormone (FSH)
B. Anti-Mullerian Hormone (AMH) [CORRECT]
, C. Inhibin B
D. Estradiol
Correct Answer: B
Rationale: AMH is produced by granulosa cells of growing follicles and is a direct marker of ovarian reserve. In POI,
AMH is markedly decreased or undetectable, making it the most useful biomarker for confirming diminished ovarian
reserve. While FSH is elevated in POI (diagnostic threshold of 25 IU/L on two checks 4-6 weeks apart), AMH provides
earlier and more specific information about ovarian follicle depletion. Inhibin B also decreases with ovarian aging but is
less reliable due to cycle variability.
Q4: A 47-year-old woman asks about the average age of natural menopause. Which statement is most
accurate according to NAMS evidence?
A. The average age of natural menopause is 51 years in the United States [CORRECT]
B. The average age of natural menopause is 55 years globally
C. The average age of natural menopause is 45 years in Black women
D. The average age of natural menopause has been declining over the past two decades
Correct Answer: A
Rationale: The average age of natural menopause in the United States is approximately 51 years, which is consistent
across multiple large cohort studies. This figure has remained relatively stable over time. While ethnicity can influence the
menopause experience (symptom severity, duration), the average age of natural menopause does not differ substantially
by race or ethnicity. Early menopause is defined as age 40-45, and premature menopause (POI) is defined as age less
than 40.
Q5: A perimenopausal woman presents with a transient elevation in estradiol followed by a sharp
decline. Her clinician explains that an elevated FSH recruited a second follicle during the luteal phase,
causing a brief estrogen surge. What is this phenomenon called?
A. Luteal Out-of-Phase (LOOP) Event [CORRECT]
B. Follicular Escape Phenomenon
C. Anovulatory Estrogen Surge
D. Luteal Phase Defect
Correct Answer: A
Rationale: The Luteal Out-of-Phase (LOOP) event occurs when elevated FSH during the perimenopause transition
recruits a second cohort of follicles, causing a transient estradiol elevation. This phenomenon is unique to perimenopausal
women and reflects the loss of normal negative feedback regulation. The subsequent decline in estradiol contributes to
vasomotor symptoms and menstrual irregularity. It is not a follicular escape, anovulatory surge, or luteal phase defect.
Q6: A clinician is counseling a 44-year-old woman who has experienced 45 consecutive days without a
menstrual period. According to STRAW+10 staging criteria, which classification applies?
A. Stage -2 (Early Menopause Transition)
B. Stage -1 (Late Menopause Transition) [CORRECT]
C. Stage 0 (Final Menstrual Period)
D. Stage +1a (Early Postmenopause)
Correct Answer: B
Rationale: STRAW+10 classifies Stage -1 (Late Menopause Transition) by the occurrence of 60 or more consecutive days
of amenorrhea. This patient has 45 days, which does not meet the 60-day threshold, so she remains in Stage -2. The key
distinction is that Stage -2 involves cycle length variability of 7 or more days, while Stage -1 is defined by prolonged
amenorrhea of at least 60 days. The Final Menstrual Period (Stage 0) is identified retrospectively after 12 months of
, amenorrhea.
Q7: Which hormone level is NOT required for the diagnosis of menopause in a woman older than 45
years with classic symptoms?
A. FSH
B. Estradiol
C. TSH
D. Both FSH and estradiol are not routinely required [CORRECT]
Correct Answer: D
Rationale: In women older than 45 with classic menopausal symptoms (vasomotor symptoms, menstrual irregularity), the
diagnosis of menopause can be made clinically without laboratory testing. Both FSH and estradiol fluctuate substantially
during the menopause transition and are not required for diagnosis in this age group. TSH should be checked to rule out
thyroid dysfunction as a cause of symptoms, but it is not used to diagnose menopause itself. Laboratory evaluation is
indicated for women with atypical symptoms or younger age.
Q8: A 38-year-old woman presents with amenorrhea for 5 months, FSH of 42 IU/L on two
measurements taken 5 weeks apart, and an estradiol level of 18 pg/mL. Which condition is most
consistent with these findings?
A. Natural menopause
B. Premature ovarian insufficiency (POI) [CORRECT]
C. Stage -1 Late Menopause Transition
D. Hypothalamic amenorrhea
Correct Answer: B
Rationale: POI is diagnosed in women under age 40 with amenorrhea for 3-4 months or more and elevated FSH (25
IU/L or higher) on two occasions measured 4-6 weeks apart. This patient meets all criteria: age under 40, 5 months of
amenorrhea, FSH of 42 IU/L (above the 25 IU/L threshold) on two checks 5 weeks apart, and low estradiol consistent
with ovarian failure. Natural menopause at age 38 is premature menopause, which by definition is POI. Hypothalamic
amenorrhea would present with low or normal FSH, not elevated.
Q9: During the late postmenopausal stage (Stage +2) of STRAW+10, which clinical features
predominate?
A. Vasomotor symptoms are at their peak intensity
B. Somatic aging effects predominate and genitourinary symptoms increase [CORRECT]
C. Menstrual irregularity is the primary concern
D. FSH levels stabilize and estradiol levels recover
Correct Answer: B
Rationale: Stage +2 (Late Postmenopause) occurs 5-8 years after the Final Menstrual Period. During this stage, the
effects of somatic aging predominate over those directly related to estrogen decline. Genitourinary symptoms such as
vaginal dryness, dyspareunia, and urinary urgency increase due to prolonged estrogen deficiency. VMS typically peak
during the early menopause transition and early postmenopause, not in the late postmenopausal stage. FSH remains
elevated and estradiol remains low; neither recovers.
Q10: Inhibin B decreases during reproductive aging primarily because of which mechanism?
A. Decreased hypothalamic GnRH secretion
B. Reduced number of developing ovarian follicles [CORRECT]
C. Increased sex hormone-binding globulin (SHBG)
